Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk than insulin
Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born ...
Dec 11, 2023
0
3